Zhang X, Yang J, Li J, Qiu L, et al. Analysis of 60 patients with relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma treated with CD7-targeted chimeric antigen receptor-T cell therapy. Am J Hematol 2023 Sep 23. doi: 10.1002/ajh.27094.
PMID: 37740926